Cargando…

Predictors of motor complications in early Parkinson's disease: A prospective cohort study

OBJECTIVE: The objective of this study was to identify clinical predictors of motor complications (dyskinesia and motor fluctuations) of levodopa in a prospectively recruited PD cohort using longitudinal analysis. METHODS: An inception cohort (Oxford Discovery) of 734 patients was followed to a maxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelly, Mark J., Lawton, Michael A., Baig, Fahd, Ruffmann, Claudio, Barber, Thomas R., Lo, Christine, Klein, Johannes C., Ben‐Shlomo, Yoav, Hu, Michele T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771533/ https://www.ncbi.nlm.nih.gov/pubmed/31283854 http://dx.doi.org/10.1002/mds.27783

Ejemplares similares

Predicting motor, cognitive & functional impairment in Parkinson's
por: Lo, Christine, et al.
Publicado: (2019)

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
por: Baig, Fahd, et al.
Publicado: (2019)

Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder
por: Baig, Fahd, et al.
Publicado: (2017)

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
por: Barber, Thomas R, et al.
Publicado: (2017)

Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives
por: Baig, Fahd, et al.
Publicado: (2015)

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD
por: Arora, Siddharth, et al.
Publicado: (2018)

Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
por: Lawton, Michael, et al.
Publicado: (2015)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort
por: Lawton, Michael, et al.
Publicado: (2019)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
por: Lawton, Michael, et al.
Publicado: (2016)

Neuroimaging in pre-motor Parkinson's disease()
por: Barber, Thomas R., et al.
Publicado: (2017)

Genome-wide Analysis of Motor Progression in Parkinson Disease
por: Martínez Carrasco, Alejandro, et al.
Publicado: (2023)

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
por: Smith, Amy M., et al.
Publicado: (2018)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Predictors of cognitive impairment in an early stage Parkinson’s disease cohort
por: Hu, Michele T M, et al.
Publicado: (2014)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
por: Malek, Naveed, et al.
Publicado: (2016)

Comparison between four published definitions of hyposmia in Parkinson's disease
por: Kanavou, Sofia, et al.
Publicado: (2021)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
por: Sandor, Cynthia, et al.
Publicado: (2022)

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson’s Disease
por: Tan, Manuela M.X., et al.
Publicado: (2021)

Predictors and prognosis of population-based subjective cognitive decline: longitudinal evidence from the Caerphilly Prospective Study (CaPS)
por: Ball, Harriet A, et al.
Publicado: (2023)

Factors associated with motor complications in Parkinson's disease
por: Kadastik‐Eerme, Liis, et al.
Publicado: (2017)

Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder
por: Drew, Daniel S, et al.
Publicado: (2020)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
por: Winchester, Laura, et al.
Publicado: (2022)

Medical Management and Prevention of Motor Complications in Parkinson’s Disease
por: Aradi, Stephen D., et al.
Publicado: (2020)

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
por: Silverdale, Monty A., et al.
Publicado: (2018)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Gut Feelings About α‐Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?
por: Ruffmann, Claudio, et al.
Publicado: (2016)

The Association Between Frailty and Parkinson’s Disease in the ReSPOnD Trial
por: Smith, Natalie, et al.
Publicado: (2021)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

Gene polymorphisms and motor levodopa‐induced complications in Parkinson's disease
por: Michałowska, Małgorzata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vd4elcc9tles3uc3sg8v62021